Sorrento Therapeutics Inc (NASDAQ: SRNE) And Mayo Clinic Move Into A Research Collaboration Agreement

The stock of Sorrento Therapeutics Inc (NASDAQ: SRNE) rose to $9.46 after gaining 6.65%. The company moves into a research collaboration agreement that will rely upon the Sofusa Lymphatic Drug Delivery System (S-LDDS) technology in its undertakings. It collaborates with Mayo Clinic in the deal, hoping to make a breakthrough in the […]